Grand Rounds, a staple of American medical education for more than 100 years, spans every field of clinical practice. It is a master class on the art and science of medicine, delivered by renowned clinicians in academic settings nationwide. Yet in today's practice, where time is an all-too precious commodity, regular attendance at Grand Rounds sessions has become increasingly difficult. In response to this challenge, ReachMD brings the lecture hall to you, with these outstanding talks from top academic centers across the country.
Date | Title & Description | Contributors |
---|---|---|
2018-11-07 | Guest: Charles E. Miller, MD, FACOG Whenever the topic of establishing minimally invasive hysteroscopic surgery in the office setting comes up, many physicians ask why and how. Leveraging decades of professional experience, this activity answers thos... | |
2018-11-07 | Guest: Charles E. Miller, MD, FACOG Whenever the topic of establishing minimally invasive hysteroscopic surgery in the office setting comes up, many physicians ask why and how. Leveraging decades of professional experience, this activity answers thos... | |
2018-07-30 |
Role of Fetal Fibronectin (fFN) in the Risk-Assessment for Preterm Birth (PTB) Guest: Cynthia Gyamfi-Bannerman, MD, BSc, MSc About 30% of preterm labor spontaneously resolves and 50% of patients hospitalized for preterm labor actually give birth at term. Clinicians are left with the task to effectively assess women who are at r... |
|
2018-07-30 |
Role of Fetal Fibronectin (fFN) in the Risk-Assessment for Preterm Birth (PTB) Guest: Cynthia Gyamfi-Bannerman, MD, BSc, MSc About 30% of preterm labor spontaneously resolves and 50% of patients hospitalized for preterm labor actually give birth at term. Clinicians are left with the task to effectively assess women who are at r... |
|
2018-05-23 |
Clinical Debates in Multiple Myeloma: Putting Evidence Into Context Guest: Sagar Lonial, MD, FACP The treatment armamentarium for multiple myeloma (MM) has expanded significantly in recent years, with 6 new agents or indications approved by the US Food & Drug Administration since 2015. Treatment options now i... |
|
2018-05-23 |
Clinical Debates in Multiple Myeloma: Putting Evidence Into Context Guest: Sagar Lonial, MD, FACP The treatment armamentarium for multiple myeloma (MM) has expanded significantly in recent years, with 6 new agents or indications approved by the US Food & Drug Administration since 2015. Treatment options now i... |
|
2017-12-12 |
Case Challenges in MS: Tailoring Therapy to Patient-Specific Characteristics Guest: Scott Newsome, DO, MSCS, FAAN The complexity and heterogeneity of multiple sclerosis (MS) pathogenesis renders its clinical course and response to therapy highly variable, particularly among special populations. This includes patients consider... |
|
2017-12-12 |
Case Challenges in MS: Tailoring Therapy to Patient-Specific Characteristics Guest: Scott Newsome, DO, MSCS, FAAN The complexity and heterogeneity of multiple sclerosis (MS) pathogenesis renders its clinical course and response to therapy highly variable, particularly among special populations. This includes patients consider... |
|
2017-11-27 | Guest: Charles E. Miller, MD, FACOG This Grand Round activity leverages decades of professional experience with minimally invasive hysteroscopic surgery (MIS) in the office setting. Learn the Why? and How? of establishing a successful in-office MIS p... | |
2017-11-27 |
Advance Management of Preterm Labor: With Case Illustrations Guest: Martin R. Chavez, MD, FACOG About 30% of preterm labor spontaneously resolves and 50% of patients hospitalized for preterm labor actually give birth at term. Clinicians are left with the task to effectively assess women who are at risk for pre... |